BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37181108)

  • 1. New avenues for therapy in mitochondrial optic neuropathies.
    Ng WSV; Trigano M; Freeman T; Varrichio C; Kandaswamy DK; Newland B; Brancale A; Rozanowska M; Votruba M
    Ther Adv Rare Dis; 2021; 2():26330040211029037. PubMed ID: 37181108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hereditary Optic Neuropathies].
    Rüther K
    Klin Monbl Augenheilkd; 2018 Jun; 235(6):747-763. PubMed ID: 29490390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial dysfunction as a cause of optic neuropathies.
    Carelli V; Ross-Cisneros FN; Sadun AA
    Prog Retin Eye Res; 2004 Jan; 23(1):53-89. PubMed ID: 14766317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.
    Lopez Sanchez MI; Crowston JG; Mackey DA; Trounce IA
    Pharmacol Ther; 2016 Sep; 165():132-52. PubMed ID: 27288727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant Optic Atrophy and Leber's Hereditary Optic Neuropathy: Update on Clinical Features and Current Therapeutic Approaches.
    Chun BY; Rizzo JF
    Semin Pediatr Neurol; 2017 May; 24(2):129-134. PubMed ID: 28941528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial optic neuropathies.
    Carelli V; La Morgia C; Yu-Wai-Man P
    Handb Clin Neurol; 2023; 194():23-42. PubMed ID: 36813316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy.
    Asanad S; Tian JJ; Frousiakis S; Jiang JP; Kogachi K; Felix CM; Fatemeh D; Irvine AG; Ter-Zakarian A; Falavarjani KG; Barboni P; Karanjia R; Sadun AA
    Curr Eye Res; 2019 Jun; 44(6):638-644. PubMed ID: 30649972
    [No Abstract]   [Full Text] [Related]  

  • 8. [Past, present, and future in Leber's hereditary optic neuropathy].
    Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):809-27. PubMed ID: 11802455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LHON and other optic nerve atrophies: the mitochondrial connection.
    Howell N
    Dev Ophthalmol; 2003; 37():94-108. PubMed ID: 12876832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of hereditary optic neuropathies.
    La Morgia C; Carbonelli M; Barboni P; Sadun AA; Carelli V
    Front Neurol; 2014; 5():141. PubMed ID: 25132831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [How to distinguish between autosomal dominant optic atrophy and Leber's hereditary optic neuropathy].
    Leo-Kottler B; Jägle H; Küpker T; Schimpf S
    Ophthalmologe; 2007 Dec; 104(12):1060-5. PubMed ID: 17899121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant optic atrophy.
    Lenaers G; Hamel C; Delettre C; Amati-Bonneau P; Procaccio V; Bonneau D; Reynier P; Milea D
    Orphanet J Rare Dis; 2012 Jul; 7():46. PubMed ID: 22776096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies.
    Carelli V; Ross-Cisneros FN; Sadun AA
    Neurochem Int; 2002 May; 40(6):573-84. PubMed ID: 11850115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatments in Leber's hereditary optic neuropathy].
    Hage R
    J Fr Ophtalmol; 2022 Nov; 45(8S1):S24-S31. PubMed ID: 36529474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
    Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
    PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial oxidative phosphorylation compensation may preserve vision in patients with OPA1-linked autosomal dominant optic atrophy.
    Van Bergen NJ; Crowston JG; Kearns LS; Staffieri SE; Hewitt AW; Cohn AC; Mackey DA; Trounce IA
    PLoS One; 2011; 6(6):e21347. PubMed ID: 21731710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern opportunities and prospects for studying pathogenesis, diagnosing and treating hereditary optic neuropathies].
    Sheremet NL; Khanakova NA; Nevinitsyna TA; Tsygankova PG; Itkis IuS; Krylova TD; Loginova AN; Chukhrova AL; Venkova LS; Svistunova DM; Chernoivanenko IS; Zakharova EIu; Poliakov AV; Minin AA
    Vestn Oftalmol; 2014; 130(6):62-70. PubMed ID: 25715555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy.
    Fuhrmann N; Schimpf S; Kamenisch Y; Leo-Kottler B; Alexander C; Auburger G; Zrenner E; Wissinger B; Alavi MV
    Mol Neurodegener; 2010 Jun; 5():25. PubMed ID: 20546606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic neuropathies--importance of spatial distribution of mitochondria as well as function.
    Yu Wai Man CY; Chinnery PF; Griffiths PG
    Med Hypotheses; 2005; 65(6):1038-42. PubMed ID: 16098682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy.
    Alavi MV; Bette S; Schimpf S; Schuettauf F; Schraermeyer U; Wehrl HF; Ruttiger L; Beck SC; Tonagel F; Pichler BJ; Knipper M; Peters T; Laufs J; Wissinger B
    Brain; 2007 Apr; 130(Pt 4):1029-42. PubMed ID: 17314202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.